5:11 PM
 | 
Apr 16, 2013
 |  BC Extra  |  Company News

FDA approves abuse-deterrent labeling for OxyContin

FDA said it will not accept or approve ANDAs for generic versions of OxyContin oxycodone that lack abuse-deterrent properties. The news follows the agency's approval of abuse-deterrent labeling for the reformulated version...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >